Our Services
Medical Information
Helpful Resources
Published on: 1/30/2026
Yes. Inflammatory bowel disease can increase the risk of certain cancers, especially colorectal cancer; risks also include small bowel and anal cancers, and some immune-suppressing treatments slightly raise lymphoma and non-melanoma skin cancer risk. Most people with IBD do not develop cancer, and with regular colonoscopy starting 8 to 10 years after diagnosis and then every 1 to 3 years, good inflammation control, and not smoking, the risk can often be managed. There are several factors to consider, and key warning signs and risk modifiers are explained below to help guide your next steps.
Inflammatory bowel disease (IBD) is a term used to describe chronic inflammation of the digestive tract, mainly ulcerative colitis and Crohn's disease. A common and understandable question people ask after an IBD diagnosis is whether IBD can lead to cancer.
The short answer is yes, IBD can increase the risk of certain cancers, especially cancers of the digestive system. However, it is important to put this risk into context. Most people with IBD do not develop cancer, and modern treatments, monitoring, and lifestyle steps significantly reduce the danger.
This article explains the relationship between IBD and cancer in clear, practical terms, using information based on well-established medical research and clinical guidelines.
IBD causes ongoing inflammation in the intestines. Unlike short-term inflammation that helps the body heal, long-lasting inflammation can damage tissue over time.
In IBD, this ongoing inflammation can:
The duration, severity, and location of inflammation are key factors in determining cancer risk.
Colorectal cancer is the most well-established cancer risk linked to IBD.
People at higher risk include those who:
Ulcerative colitis generally carries a higher colorectal cancer risk than Crohn's disease, but Crohn's colitis (Crohn's affecting the colon) also increases risk.
Important perspective:
With modern colonoscopy surveillance and better medications, the risk of colorectal cancer in people with IBD has decreased significantly over the past few decades.
Small bowel cancer is rare in the general population, but people with Crohn's disease involving the small intestine have a higher risk compared to those without IBD.
This risk remains low overall, but doctors take it seriously when symptoms change or worsen unexpectedly.
People with long-standing perianal Crohn's disease, especially those with chronic fistulas, may have an increased risk of anal cancer. This risk is still uncommon but requires careful monitoring.
Some IBD treatments suppress the immune system. Certain medications, particularly:
have been associated with a small increased risk of:
It's important to note:
Not everyone with IBD has the same cancer risk. Factors that matter include:
Managing these factors can dramatically lower cancer risk.
One of the most important ways to reduce cancer risk in IBD is regular medical surveillance.
For many people with IBD, this includes:
These screenings are designed to find problems early, when they are most treatable—or even prevent cancer from developing at all.
IBD symptoms can overlap with other digestive conditions. For example, if you're experiencing chronic digestive discomfort but haven't been diagnosed with IBD, it's worth exploring whether Irritable Bowel Syndrome (IBS) might explain your symptoms—a common condition that shares some similarities with IBD but does not cause inflammation or increase cancer risk.
While IBD-related cancer risk cannot be eliminated entirely, many steps can reduce it:
Good disease control is one of the strongest protective factors.
Even though anxiety is understandable, awareness is empowering. Speak to a doctor right away if you experience:
These symptoms do not automatically mean cancer, but they do require medical evaluation.
It is true that IBD increases the risk of certain cancers. However:
Early diagnosis, consistent treatment, and regular follow-up make a meaningful difference.
Inflammatory bowel disease (IBD) can increase the risk of some cancers, particularly colorectal cancer, due to long-term inflammation. Still, with today's medical knowledge, careful monitoring, and effective treatments, this risk can often be managed successfully.
If you have IBD—or symptoms that concern you—do not rely on guesswork or online information alone. Speak to a doctor about anything that could be serious or life-threatening. Open, ongoing communication with a healthcare professional is one of the most powerful tools for protecting your long-term health.
(References)
* Axelrad, J. E., & Ungaro, R. (2023). Colorectal Cancer and Inflammatory Bowel Disease: Risk, Prevention, and Management. Gastroenterology Clinics of North America, 52(3), 517-531.
* Liang, X., Li, X., Wu, Q., Zhai, X., & Li, C. (2023). Inflammatory Bowel Disease and Its Associated Colorectal Cancer: Epidemiological Trends, Mechanisms, and Clinical Interventions. Cancers, 15(13), 3350.
* Rogler, G., & D'Haens, G. R. (2020). Inflammatory Bowel Disease and Cancer: The Link, Mechanisms, and Implications for Management. Gastroenterology, 158(5), 1198-1207.e1.
* Jahn, M., Atreya, R., & Neurath, M. F. (2020). Inflammatory bowel disease and cancer: novel aspects of molecular carcinogenesis. F1000Research, 9, F1000 Faculty Rev-250.
* Jess, T., & Rungoe, C. (2019). Cancer risk in inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology, 40-41, 101625.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.